Skip to main content
. 2023 Sep 8;18(9):e0291259. doi: 10.1371/journal.pone.0291259

Fig 3.

Fig 3

A. Anti-nucleocapsid antibody levels during follow-up. B. Median anti-spike antibody levels during follow-up after vaccination.